STENTARELLI, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 6.339
EU - Europa 3.612
AS - Asia 2.205
SA - Sud America 315
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
Totale 12.534
Nazione #
US - Stati Uniti d'America 6.258
GB - Regno Unito 2.024
CN - Cina 716
SG - Singapore 711
SE - Svezia 365
HK - Hong Kong 307
IT - Italia 307
DE - Germania 281
BR - Brasile 268
TR - Turchia 160
UA - Ucraina 144
RU - Federazione Russa 126
VN - Vietnam 110
FI - Finlandia 106
FR - Francia 67
BG - Bulgaria 51
CA - Canada 48
IN - India 45
ID - Indonesia 29
ZA - Sudafrica 26
MX - Messico 25
KR - Corea 21
SI - Slovenia 21
JP - Giappone 17
MY - Malesia 16
BE - Belgio 15
BD - Bangladesh 14
IQ - Iraq 14
NL - Olanda 14
ES - Italia 13
PL - Polonia 13
AR - Argentina 12
EC - Ecuador 12
IE - Irlanda 9
PK - Pakistan 9
AT - Austria 8
LT - Lituania 8
RO - Romania 7
CO - Colombia 6
CZ - Repubblica Ceca 6
MA - Marocco 6
PH - Filippine 6
CH - Svizzera 5
IR - Iran 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
VE - Venezuela 5
CL - Cile 4
EU - Europa 4
JO - Giordania 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
AZ - Azerbaigian 3
EG - Egitto 3
ET - Etiopia 3
NG - Nigeria 3
TH - Thailandia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
DK - Danimarca 2
GH - Ghana 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
LU - Lussemburgo 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
ZW - Zimbabwe 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
UY - Uruguay 1
Totale 12.534
Città #
Southend 1.786
Santa Clara 629
Ashburn 554
Fairfield 549
Woodbridge 465
Singapore 463
Chandler 459
Hong Kong 307
Houston 298
Jacksonville 286
Ann Arbor 248
Dearborn 241
Seattle 226
Wilmington 220
Cambridge 199
Beijing 189
Nyköping 159
London 128
Modena 115
Hefei 111
Izmir 104
Los Angeles 100
Dallas 91
New York 91
Chicago 88
Princeton 70
Munich 58
Eugene 51
Sofia 51
Shanghai 47
San Diego 45
Helsinki 37
Moscow 36
Salt Lake City 36
The Dalles 36
Bremen 32
Ho Chi Minh City 32
Council Bluffs 30
São Paulo 28
Boardman 26
Buffalo 25
Redwood City 25
Hanoi 23
Columbus 22
Seoul 20
Jakarta 19
Turku 19
Milan 18
Tampa 18
Phoenix 16
Brussels 12
Chennai 12
Falls Church 12
Frankfurt am Main 12
Halifax 12
Toronto 12
Warsaw 12
Atlanta 11
Bologna 11
Johannesburg 11
Rio de Janeiro 11
Tokyo 11
Elk Grove Village 10
Lancaster 10
Norwalk 10
San Francisco 10
Stockholm 10
Bengaluru 9
Dublin 9
Guangzhou 9
Mexico City 9
Montreal 9
Nanjing 9
Sterling 9
Tuscaloosa 9
Brooklyn 8
Dong Ket 8
Faenza 8
Falkenstein 8
Kunming 8
Poplar 8
Chengdu 7
Da Nang 7
Ferrara 7
Fremont 7
Rome 7
Augusta 6
Brasília 6
Denver 6
Detroit 6
Dongguan 6
Indiana 6
Jinan 6
Miami 6
Nuremberg 6
Orem 6
Paris 6
Parma 6
Quito 6
San Mateo 6
Totale 9.354
Nome #
Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: An Italian cost impact study 779
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 740
Erectile dysfunction is more common in young to middle-aged HIV-infected men than in HIV-uninfected men. 403
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity 402
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 368
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 345
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles 313
Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study 285
Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients 284
Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients 281
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 280
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 262
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 251
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 243
Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010. 243
HIV patients undergoing second generation antipsychotics show high cardiovascular disease burden 242
Prediction of hard cardiovascular events in HIV patients 240
MR techniques in the qualitative analysis of liver steatosis: the potential in the differentiation between steatohepatatis and steatosis 237
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 237
American College of Cardiology pooled equations and DAD algorithm to predict freedom from cardiovascular events in HIV patients 230
Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment 228
Body Composition changes in ageing HIV infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia. 225
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women. 225
Prevalence and predictors of preclinical coronary heart disease in post-menopause period 223
ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 220
Changes with menopause in the distribution of frailty index (FI) in HIV infected women. 219
Should we screen for NAFLD/NASH in HIV patients? 217
Combined use of waist and thigh circumference to identify high-risk,, abdominally obese HIV+ patients. 213
MR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends 210
Metabolic alterations in HIV-infected pregnant women: moving to metabolic tailoring of antiretroviral drugs. 207
Multiecho MR sequences and high-resolution magic angle spinning (HRMAS)ex-vivo spectroscopy in the qualitative analysis and differentiationbetween steatohepatitis and steatosis 205
Predictors of transitions in frailty severity and mortality among people aging with HIV 202
Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 201
HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy 198
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 197
MR techiniques in the quantitative assessment of liver steatosis 188
Multimorbidity and functional status assessment 185
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT AND NON-PREGNANT WOMEN OF CHILDBEARING AGE 183
Two methods of measuring frailty among people aging with HIV 178
How do frailty mediate pathway leading to disability 177
HIGH PREVALENCE OF VITAMIN D DEFICIENCY IN A COHORT OF HIV INFECTED PREGNANT WOMEN AND ITS IMPACT ON PREGNANCY OUTCOME 177
HR-MAS NMR SPECTROSCOPY FOR CHARACTERIZATION OF STEATOSIC LIVER: FAT QUANTIFICATION FOR A SPECTROSCOPIC DIFFERENTIATION BETWEEN STEATOSIS AND STEATOHEPATITIS 172
Health transitions in HIV-seropositive individulas undergoing NRTI-based and NRTI-sparing treatment strategies. 169
Impact of Antiretroviral Medications on Fasting Lipid Parameters 155
Menopause in HIV-infected women: somewhat different? 155
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 154
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 148
Tesamorelin for the treatment of excess abdominal fat in HIV-infected individuals with lipodistrophy 147
Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients - Reply to Remtulla and Decker 142
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 142
Renal hyperfiltration and outcome in HIV-infected subjects. 135
Clinical evaluation is better than risk prediction algorithms to identify patients who need statin therapy. 128
null 49
L’epatopatia non alcolica da accumulo di grasso (NAFLD) in HIV: dallo screening al trattamento 38
Totale 12.677
Categoria #
all - tutte 44.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.446


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021870 0 0 0 0 0 127 112 174 89 165 120 83
2021/20221.128 46 159 99 132 19 60 48 72 119 82 160 132
2022/20231.132 118 139 91 117 139 162 9 130 136 20 30 41
2023/2024694 29 47 43 66 155 94 42 85 12 8 43 70
2024/20252.176 65 53 34 158 474 306 144 144 263 76 198 261
2025/20262.047 248 123 312 506 793 65 0 0 0 0 0 0
Totale 12.677